Genetics and psychopharmacology: prospects for individualized treatment.

about

Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.A preliminary study of association of genetic variants with early response to olanzapine in schizophrenia.

P2860

Q36946132-6781B464-1B6C-403E-BA8B-B1FBCD37BE76 Q55342505-74E00850-F312-4ECB-9DEA-F210306D1E00

P2860

Genetics and psychopharmacology: prospects for individualized treatment.

Item

http://www.wikidata.org/entity/Q36206096

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Genetics and psychopharmacology: prospects for individualized treatment.

@ast

Genetics and psychopharmacology: prospects for individualized treatment.

@en

type

Item

label

Genetics and psychopharmacology: prospects for individualized treatment.

@ast

Genetics and psychopharmacology: prospects for individualized treatment.

@en

prefLabel

Genetics and psychopharmacology: prospects for individualized treatment.

@ast

Genetics and psychopharmacology: prospects for individualized treatment.

@en

P1476

Genetics and psychopharmacology: prospects for individualized treatment

@en

P2093

Anil K Malhotra

http://www.w3.org/2001/XMLSchema#string

Charles U Nnadi

http://www.w3.org/2001/XMLSchema#string

Joseph F Goldberg

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.

Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia.

Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes.

Benefits and pitfalls encountered in psychiatric genetic association studies.

Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis.

Pharmacogenomics: translating functional genomics into rational therapeutics.

P304

193-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16041916

http://www.w3.org/2001/XMLSchema#string

P932

2268899

http://www.w3.org/2001/XMLSchema#string

Genetics and psychopharmacology: prospects for individualized treatment.

about

P2860

P2860

Genetics and psychopharmacology: prospects for individualized treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932